Delivery Order SPE2DR25D9144-SPE2DR26FDJF2
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, was awarded without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a $1,113.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,227.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The award was issued on December 9, 2025, with an ultimate completion date of December 31, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is competing effectively in unrestricted federal procurement...
- The Defense Logistics Agency awarded a $22,270.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,783.80 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in one-dose vial quantities. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order, issued on November 5, 2025, with an...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,919.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, reflecting the contractor's competitive capability in...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in single-dose vials. The award was made on December 9, 2025, with an ultimate completion date of December 31, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The contract is classified as firm fixed-price with an ultimate completion date of January 5, 2026, and was issued without a set-aside designation, indicating the award resulted from open competition. This delivery order represents a...
- The Defense Logistics Agency issued a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) dose vials on December 4, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 26, 2025, represents a routine pharmaceutical procurement under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency. The award carries no set-aside designation, indicating competitive procurement...
- SPE2DR25D9144Indefinite Delivery Contract
- SPE2DR25D9144-SPE2DR26FDJF2Delivery Order
The Defense Logistics Agency awarded a $2,227.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, requires no set-aside designation and represents DMS Pharmaceutical Group's competitive capability in unrestricted federal pharmaceutical procurement. The award falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion umbrella contract established to supply comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial federal contracting activity as a critical supplier within the military healthcare pharmaceutical supply chain, with the company's product portfolio encompassing branded and generic medications, biologics, vaccines, and specialty pharmaceuticals. The PPV-G GEN V contract, awarded on November 13, 2025, with a completion date of December 31, 2036, features a 30-month base period and three 30-month option periods, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors supporting the Department of Defense's global medical supply requirements. This delivery order for YF-VAX exemplifies the company's role in fulfilling specialized pharmaceutical needs for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/3/25 |